mRNA Vaccination for Treating Allergy by Modulating Allergen‐Specific Immunity

iLABMED 2026 Open access

Read full text
Authors: Kundian Guo, Lijing Liu, Mingyun Shen, Karin Loré, Ang Lin
DOI: 10.1002/ila2.70047
Cited by: 0
References: 6

Abstract

This News and Views article discusses the rationale for anti-allergy vaccine development using a lipid nanoparticle-mRNA platform. The authors provide additional evidence that supports the potential of using the mRNA approach to combat allergic diseases.

Fields of Study & Subjects

Allergic Rhinitis and Sensitization RNA Interference and Gene Delivery Immunotherapy and Immune Responses

Publication details

Journal / source
iLABMED
Volume
4
Issue
1
Pages
56–58
Publication date
6 January 2026
Language
EN